OBJECTIVES: The aim of this study was to evaluate the correlations of pre-pregnancy maternal BMI(body mass index), and weight gain during pregnancy with Birth weight and Cesarean delivery in full term infants. METHODS: We collected data from 1086 pregnancies without complications, and analysed pre-pregnancy maternal BMI, weight gain during pregnancy, and the incidences of SGA(small-for-gestational age), LGA(large-for-gestational age), cesarean delivery. Chi-square test, T-test, and One way Anova test were performed for stastatical analysis. RESULTS: In pre-pregnancy maternal BMI <19.8kg/m2 group, the incidence of SGA was 12.2%, LGA 6.2% and cesarean delivery 14.9% respectively, but in >26.0kg/m2 group, 0%, 23.6% and 36.4% respectively(p<0.05). In under weight gain during pregnancy group, incidence of SGA was 13.4%, LGA 4.7% and cesarean delivery 15.7% respectively, but in high weight gain group, 4.8%, 19.5% and 21.0% respectively(p<0.05). CONCLUSION: There was significant correlations among pre-pregnancy maternal BMI, weight gain during pregnancy, birth weight and cesarean delivery. From these results, it is considered that antenatal maternal BMI and weight gain during pregnancy are valuable to predict birth weight and cesarean delivery.
Birth Weight* ; Body Mass Index* ; Humans ; Incidence ; Infant ; Parturition* ; Pregnancy ; Weight Gain

OBJECTIVE: To evaluate the clinical and histopathological features, treatment and prognosis of borderline ovarian tumors (BOT). METHODS: Thirty nine cases of BOT were treated between January 1985 and December 2001 at Maryknoll Hospital. All of BOT were classified in accordance with the WHO criteria for histological typing and clinical staging according to the FIGO system. The clinical records of all patients were reviewed retrospectively. RESULTS: The incidence of BOT was 21.0% (39/186) of epithelial ovarian malignancies and patients with these tumors tended to present at younger age (36.6 years old) than those with invasive carcinoma (53.6 years old). Fourteen patients (35.9%) were nullipara. The most common chief complaint was palpable mass (28.2%). Serous type (17.9%) occurred less frequently than mucinous type (76.9%). The positive ratio of CA 125 was 45%. Stage I was 37 cases (94.8%), stage II, 1 case (2.6%), and stage III, 1 case (2.6%). The mean size of mucinous tumors was larger than that of serous types (18.7 cm vs 10.0 cm). Twenty three (59%) cases were managed by conservative surgery (unilateral salpingo-oophorectomy) and sixteen cases (41%) by extirpative operation. Post-operative adjuvant chemotherapy was given to seven patients (17.9%). Median follow-up period was 30 months. One patient expired in case of mucinous tumor and seven cases lost during follow-up. Overall survival rate was 96.9%. CONCLUSION: Borderline ovarian tumors constitute approximately 21.0% of epithelial ovarian malignancy and occur in younger patients than those with invasive cancer. It is mostly seen serous and mucinous types and most of them are diagnosed at early stage making definite treatment possible.
Chemotherapy, Adjuvant ; Female ; Follow-Up Studies ; Humans ; Incidence ; Mucins ; Ovary* ; Prognosis ; Retrospective Studies ; Survival Rate